Drug class in one race

α2δ-1 subunit of voltage-gated calcium channels drugs for Diabetic Peripheral Neuropathic Pain

2 tracked α2δ-1 subunit of voltage-gated calcium channels drugs in the Diabetic Peripheral Neuropathic Pain race. The class explanation lives on the α2δ-1 subunit of voltage-gated calcium channels page; the full indication pipeline across every mechanism is on the Diabetic Peripheral Neuropathic Pain page.

1 Phase 31 Phase 2/3

Head-to-head evidence: Crisugabalin vs Mirogabalin

The roster

← all α2δ-1 subunit of voltage-gated calcium channels drugs